Dr Brannan is chief medical officer at Karuna Therapeutics and a neuroscience drug development expert.
Promising Publication: The Novel Schizophrenia Treatment Gaining Traction
Data published in The New England Journal of Medicine shows promise for a novel schizophrenia treatment.
New Mechanism for Treatment of Schizophrenia
Hear details from the phase II trial of xanomeline-trospium and how it assists in the treatment of acute schizophrenia.
2 Clarke Drive Cranbury, NJ 08512